Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05296525 |
Title | Evaluation of Safety and Efficacy of Allo GDA-201 NK Cells in Patients With Relapsed/Refractory B Cell NHL |
Recruitment | Terminated |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Gamida Cell ltd |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Mayo Clinic Jacksonville | Jacksonville | Florida | 32224 | United States | Details | |
Loyola University, Cardinal Bernardin Cancer Center | Maywood | Illinois | 60153 | United States | Details | |
Dana-Farber/Mass General Brigham Cancer Care, Inc. | Boston | Massachusetts | 02215 | United States | Details | |
Henry Ford Medical Center | Detroit | Michigan | 48202 | United States | Details | |
Regents of the University of Minnesota | Minneapolis | Minnesota | 55455 | United States | Details | |
Memorial Sloan Kettering Cancer Center (MSKCC) - Memorial Hospital | New York | New York | 10065 | United States | Details |